Browsing by Subject Huntington's chorea
Showing results 1 to 20 of 89
next >
| Issue Date | Title | Author(s) |
|---|---|---|
| 30-Jun-2010 | A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing | Martí Puig, Eulàlia; Pantano, Lorena; Bañez-Coronel, Mónica; Llorens Torres, Franc; Miñones Moyano, Elena; Porta, Sílvia; Sumoy, Lauro; Ferrer, Isidro (Ferrer Abizanda); Estivill, Xavier, 1955- |
| 23-Feb-2012 | A pathogenic mechanism in Huntington"s disease involves small CAG-repeated RNAs with neurotoxic activity | Bañez-Coronel, Mónica; Porta, Sílvia; Kagerbauer, Birgit; Mateu Huertas, Elisabet; Pantano, Lorena; Ferrer, Isidro (Ferrer Abizanda); Guzmán, Manuel; Estivill, Xavier, 1955-; Martí Puig, Eulàlia |
| 20-Jul-2017 | A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington's disease mice | Suelves Caballol, Núria; Kirkham-McCarthy, Lucy; Lahue, Robert S.; Ginés Padrós, Silvia |
| Aug-2018 | A systematic linguistic profile of spontaneous narrative speech in pre-symptomatic and early stage Huntington's disease. | Hinzen, Wolfram; Rosselló Ximenes, Joana; Morey, Caty; Camara Mancha, Estela; García-Gorro, Clara; Salvador, Raymond; Diego Balaguer, Ruth de |
| 11-Jul-2022 | Altered m6A RNA methylation contributes to hippocampal memory deficits in Huntington's disease mice. | Pupak, Anika; Singh, Ankita; Sancho Balsells, Anna; Alcalá Vida, Rafael; Espina, Marc; Giralt Coll, Albert; Martí Puig, Eulàlia; Vang Ørom, Ulf Andersson; Ginés Padrós, Silvia; Brito, Verónica |
| 20-Oct-2004 | Biochemical, ultrastructural, and reversiblity studies on Huntingtin filaments isolated from mouse and human brain | Díaz-Hernández, Miguel; Moreno-Herrero, Fernando; Gómez-Ramos, Pilar; Morán, María A.; Ferrer, Isidro (Ferrer Abizanda); Baró, Arturo M.; Avila, Jesús; Hernández, Félix; Lucas, José J. |
| 18-Jun-2007 | Caracterización de efectores de diferenciación GABAérgica en células madre como herramienta terapéutica de enfermedades neurodegenerativas. | Martín Ibáñez, Raquel |
| 2-Dec-2019 | CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease | Comella Bolla, Andrea; Valente, Tony; Miguez, Andrés; Brito, Verónica; Ginés Padrós, Silvia; Solà i Subirana, Carme; Straccia, Marco; Canals i Coll, Josep M. |
| 22-Jul-2013 | Characterization of mechanisms underlying neuronal survival and plasticity in Huntington's disease | Anglada Huguet, Marta |
| 12-Jul-2012 | Characterization of the mechanisms underlying alterations in macroautophagy and survival signalling in Huntington’s disease | Rué Cabré, Laura |
| 2012 | Cognitive dysfunction in Huntington¿s disease: Humans, mouse models and molecular mechanisms | Giralt Torroella, Albert; Saavedra, Ana; Alberch i Vié, Jordi, 1959-; Pérez Navarro, Esther |
| 22-Sep-2016 | COMT Val158Met Polymorphism Modulates Huntington's Disease Progression | Diego Balaguer, Ruth de; Schramm, Catherine; Rebeix, Isabelle; Dupoux, Emmanuel; Dürr, Alexandra; Brice, Alexis; Charles, Perrine; Cleret de Langavant, Laurent; Youssov, Katia; Verny, Christophe; Damotte, Vincent; Azulay, Jean-Philippe; Goizet, Cyril; Tranchant, Christine; Maison, Patrick; Rialland, Amandine; Schmitz, David; Jacquemot, Charlotte; Fontaine, Bertrand; Bachoud-Lévi, Anne-Catherine; Simonin, Clémence; French Speaking Huntington Group |
| 2011 | Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction | Giralt Torroella, Albert; Carreton, Olga; Lao-Peregrin, Cristina; Martín, Eduardo D.; Alberch i Vié, Jordi, 1959- |
| 1-Aug-2019 | Cyclin-Dependent Kinase 5 Dysfunction Contributes to Depressive-like Behaviors in Huntington's Disease by Altering the DARPP-32 Phosphorylation Status in the Nucleus Accumbens | Brito, Verónica; Giralt Torroella, Albert; Masana Nadal, Mercè; Royes, Aida; Espina, Marc; Sieiro, Esther; Alberch i Vié, Jordi, 1959-; Castañé, Anna; Girault, Jean-Antoine; Ginés Padrós, Silvia |
| 2006 | Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase | Borrell Pagès, Maria; Canals i Coll, Josep M.; Cordelières, Fabrice P.; Parker, J. Alex; Pineda Martí, José Ramón; Grange, Ghislaine; Bryson, Elzbieta A.; Guillermier, Martine; Hirsch, Etienne; Hantraye, Philippe; Cheetham, Michael E.; Néri, Christian; Alberch i Vié, Jordi, 1959-; Brouillet, Emmanuel; Saudou, Frédéric; Humbert, Sandrine |
| 1-Sep-2015 | Decreased glycogen synthase kinase-3 levels and activity contribute to Huntington's disease | Fernández-Nogales, Marta; Hernández, Félix; Miguez, Andrés; Alberch i Vié, Jordi, 1959-; Ginés Padrós, Silvia; Pérez Navarro, Esther; Lucas, José J. |
| 23-Oct-2014 | Deep white matter in Huntington's disease | Phillips, Owen R.; Squitieri, Ferdinando; Sánchez Castañeda, Cristina; Elifani, Francesca; Caltagirone, Carlo; Sabatini, Umberto; Paola, Margherita di |
| 28-May-2020 | Deficits in coordinated neuronal activity and network topology are striatal hallmarks in Huntington's disease. | Fernández García, Sara; Orlandi, Javier G.; García-Díaz Barriga, Gerardo; Rodríguez Allué, Manuel José; Masana Nadal, Mercè; Soriano i Fradera, Jordi; Alberch i Vié, Jordi, 1959- |
| 27-Nov-2014 | Description and Validation of New Therapeutical Targets to Prevent Neurodegenertlion and Cognitive Deficits in Huntington's Disease | Puigdellívol Cañadell, Maria del Mar |
| 20-Mar-2017 | Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice | Pardo Muñoz, Mònica; García-Díaz Barriga, Gerardo; Straccia, Marco; Sanders, Phil; Alberch i Vié, Jordi, 1959-; Canals i Coll, Josep M.; HD iPSC Consortium |